That means in the absence of new, vaccine-evading coronavirus variants — a big if — next fall and winter could look a lot different in Canada in terms of the impact of COVID-19. Loading external pages ...
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) ...
NewHomeSource reports that sleep is now a wellness status symbol, prompting new home designs focused on optimizing sleep ...
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") , a clinical-stage biotechnology company leveraging its proprietary Diffuspheretm technology designed to optimize local, controlled drug ...
Novo Nordisk, which makes the GLP-1 semaglutide medications Ozempic and Wegovy, announced that it’s rolling out an “Ozempic ...
Tyler McBride walked about his middle school classroom in rural Arkansas years ago during a period of silent reading as ...
The newly approved oral formulation features a smaller pill size in 1.5mg, 4mg, and 9mg strengths while maintaining the efficacy and safety profile of the previous oral semaglutide version.
Novo said the relaunched Ozempic pills are as safe and effective as Rybelsus tablets, which contain the same main ingredient, semaglutide, though in a different formulation and dose structure.
Novo Nordisk announced that starting Monday, May 4, Ozempic® (semaglutide) tablets 1.5 mg, 4 mg, and 9 mg will be available ...
Lakewood-Amedex Biotherapeutics Inc., a clinical-stage biotechnology company advancing a novel class of potent, fast-acting, broad-spectrum antimicrobials for infectious diseases called the ...
Novo Nordisk A/S is rebranding an existing, less-popular diabetes tablet as Ozempic in the US in a bid to capitalize on the ...
From painkillers to blood pressure pills – 5 common drugs behind your tinnitus and worsening hearing
ANY medication can trigger side effects – though these are often symptoms like nausea, sleepiness or dizzy spells. But some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results